search
Back to results

The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome

Primary Purpose

Tourette Syndrome

Status
Unknown status
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
deep brain stimulation (DBS)
Sponsored by
Beijing Pins Medical Co., Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tourette Syndrome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Subject is aged 18 or older
  2. Patient Group with Tourette's syndrome, Diagnosis of Tourette Syndrome by DSM-IV

Exclusion Criteria:

  1. Major Depressive Episode within the previous 6 months
  2. Schizophrenia or other psychotic disorder.Participate in other clinical trial;
  3. Has a life expectancy of < 1 year.
  4. The investigator and/or enrollment review committee, would preclude participation in the study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    Deep Brain Stimulation

    Sham Stimulation

    Arm Description

    Deep Brain Stimulation is on

    placebo

    Outcomes

    Primary Outcome Measures

    Modified Rush Video Rating Scale (mRVRS)

    Secondary Outcome Measures

    Tourette Syndrome Symptom List (TSSL)
    SF-36

    Full Information

    First Posted
    September 29, 2014
    Last Updated
    October 13, 2016
    Sponsor
    Beijing Pins Medical Co., Ltd
    Collaborators
    Beijing Tiantan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02253498
    Brief Title
    The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome
    Official Title
    The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    May 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    December 2016 (undefined)
    Primary Completion Date
    December 2018 (Anticipated)
    Study Completion Date
    December 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Beijing Pins Medical Co., Ltd
    Collaborators
    Beijing Tiantan Hospital

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    The purpose of this clinical study is to verify the long term effectiveness and safety of a bilateral deep brain stimulation (DBS) produced by Beijing PINS Medical Co., Ltd. as a treatment option for patients with cognitive, behavioral, and functional disability of Tourette Syndrome.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Tourette Syndrome

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Early Phase 1
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Deep Brain Stimulation
    Arm Type
    Experimental
    Arm Description
    Deep Brain Stimulation is on
    Arm Title
    Sham Stimulation
    Arm Type
    Sham Comparator
    Arm Description
    placebo
    Intervention Type
    Device
    Intervention Name(s)
    deep brain stimulation (DBS)
    Other Intervention Name(s)
    Implanted device
    Primary Outcome Measure Information:
    Title
    Modified Rush Video Rating Scale (mRVRS)
    Time Frame
    12 month
    Secondary Outcome Measure Information:
    Title
    Tourette Syndrome Symptom List (TSSL)
    Time Frame
    12 month
    Title
    SF-36
    Time Frame
    12 month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Subject is aged 18 or older Patient Group with Tourette's syndrome, Diagnosis of Tourette Syndrome by DSM-IV Exclusion Criteria: Major Depressive Episode within the previous 6 months Schizophrenia or other psychotic disorder.Participate in other clinical trial; Has a life expectancy of < 1 year. The investigator and/or enrollment review committee, would preclude participation in the study.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jia Fumin, PhD
    Phone
    010-59361265
    Email
    pins_medical@163.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Li Luming, PhD
    Organizational Affiliation
    Tsinghua University
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Tourette Syndrome

    We'll reach out to this number within 24 hrs